Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-003780

Options or other derivatives

  • Chief Medical Officer returned 35,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Schwartz Jonathan David · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-04 Returned to the company : show line 1 in the form Stock Option (Right to Buy) +35,000 $62.32 2031-02-03 35,000 35,000 D
Loading xslF345X03/form4.xml…